# Functional characterisation of tumour suppressor PDCD4 reveals previously undisclosed role in the control of cell adhesion

**Authors:** Veronica Dezi, Robert F Harvey, Tom Smith, Cameron H Cole, Mariavittoria Pizzinga, Mark Stoneley, Gavin D Garland, Emilie Horvilleur, Lajos Kalmar, Ritwick Sawarkar, Kathryn S Lilley, Anne E Willis

PMC · DOI: 10.1093/nar/gkag071 · Nucleic Acids Research · 2026-02-02

## TL;DR

This study reveals that the tumor suppressor PDCD4 regulates cell adhesion by affecting RNA metabolism, offering new insights into its role in cancer.

## Contribution

The study identifies a novel role for PDCD4 in regulating cell adhesion through RNA binding and nuclear localization.

## Key findings

- PDCD4 predominantly localizes in the nucleus and interacts with RNA metabolic proteins.
- PDCD4 regulates transcripts encoding cell adhesion and structural proteins.
- Nuclear localization of PDCD4 is crucial for its role in controlling cell adhesion and metastasis.

## Abstract

PDCD4 is a multifunctional RNA-binding protein that has tumour suppressor function. To more fully understand how dysregulation of this protein contributes to carcinogenesis, we have carried out a comprehensive analysis of the role of PDCD4 in RNA metabolism in untransformed epithelial cells. We show that PDCD4 predominantly localises in the nucleus, where it interacts with proteins involved in a range of different RNA metabolic processes. We find that PDCD4 knockdown is associated with significant changes in either the expression or splicing of a number of transcripts, although it appears to have an indirect role in splicing. We identified the RNA targets of PDCD4 using iCLIP and observed an enrichment in binding to transcripts encoding cell adhesion and structural proteins. Consistent with these data, we show that PDCD4 acts as a general regulator of cell adhesion, which in a tumour setting would increase the metastatic potential of cells, and demonstrate that the nuclear localisation of PDCD4 is crucial in this process. Overall, the information obtained in untransformed cells provides a new perspective for the role of PDCD4 as a tumour suppressor.

Graphical Abstract

## Linked entities

- **Genes:** PDCD4 (programmed cell death 4) [NCBI Gene 27250]
- **Proteins:** PDCD4 (programmed cell death 4)
- **Diseases:** cancer (MONDO:0004992)

## Full-text entities

- **Genes:** MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609] {aka MRTL, MYCC, bHLHe39, c-Myc}, MIR21 (microRNA 21) [NCBI Gene 406991] {aka MIRN21, hsa-mir-21, miR-21, miRNA21}, TWIST1 (twist family bHLH transcription factor 1) [NCBI Gene 7291] {aka ACS3, BPES2, BPES3, CRS, CRS1, CSO}, EIF4A1 (eukaryotic translation initiation factor 4A1) [NCBI Gene 1973] {aka DDX2A, EIF-4A, EIF4A, eIF-4A-I, eIF4A-I}, EIF4G1 (eukaryotic translation initiation factor 4 gamma 1) [NCBI Gene 1981] {aka EIF-4G1, EIF4F, EIF4G, EIF4GI, P220, PARK18}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, HNRNPC (heterogeneous nuclear ribonucleoprotein C) [NCBI Gene 3183] {aka HNRNP, HNRPC, MRD74, SNRPC}, KRT81 (keratin 81) [NCBI Gene 3887] {aka HB1, Hb-1, K81, KRTHB1, MLN137, MNLIX2}, RPS6KA2 (ribosomal protein S6 kinase A2) [NCBI Gene 6196] {aka HU-2, MAPKAPK1C, RSK, RSK3, S6K-alpha, S6K-alpha2}, MYCBP (MYC binding protein) [NCBI Gene 26292] {aka AMY-1}, JUN (Jun proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 3725] {aka AP-1, AP1, c-Jun, cJUN, p39}, ACTB (actin beta) [NCBI Gene 60] {aka BKRNS, BNS, BRWS1, CSMH, DDS1, PS1TP5BP1}, SNAI1 (snail family transcriptional repressor 1) [NCBI Gene 6615] {aka SLUGH2, SNA, SNAH, SNAIL, SNAIL1, dJ710H13.1}, MAP4K1 (mitogen-activated protein kinase kinase kinase kinase 1) [NCBI Gene 11184] {aka HPK1}, CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, CDH1 (cadherin 1) [NCBI Gene 999] {aka Arc-1, BCDS1, CD324, CDHE, ECAD, LCAM}, CDC42BPB (CDC42 binding protein kinase beta) [NCBI Gene 9578] {aka CHOCNS, MRCKB}, EIF4G2 (eukaryotic translation initiation factor 4 gamma 2) [NCBI Gene 1982] {aka AAG1, DAP5, NAT1, P97}, BLNK (B cell linker) [NCBI Gene 29760] {aka AGM4, BASH, BLNK-S, LY57, SLP-65, SLP65}, EGF (epidermal growth factor) [NCBI Gene 1950] {aka HOMG4, URG}, PNMA3 (PNMA family member 3) [NCBI Gene 29944] {aka MA3, MA5}, MUC1 (mucin 1, cell surface associated) [NCBI Gene 4582] {aka ADMCKD, ADMCKD1, ADTKD2, CA 15-3, CD227, Ca15-3}, PLEC (plectin) [NCBI Gene 5339] {aka EBS1, EBS5A, EBS5B, EBS5C, EBS5D, EBSMD}, ELAVL2 (ELAV like RNA binding protein 2) [NCBI Gene 1993] {aka HEL-N1, HELN1, HUB}, PABPC1 (poly(A) binding protein cytoplasmic 1) [NCBI Gene 26986] {aka PAB1, PABP, PABP1, PABPC2, PABPL1}, XPO1 (exportin 1) [NCBI Gene 7514] {aka CRM-1, CRM1, emb, exp1}, TWIST2 (twist family bHLH transcription factor 2) [NCBI Gene 117581] {aka AMS, BBRSAY, DERMO1, FFDD3, SETLSS, bHLHa39}, YBX1 (Y-box binding protein 1) [NCBI Gene 4904] {aka BP-8, CBF-A, CSDA2, CSDB, DBPB, EFI-A}, PDCD4 (programmed cell death 4) [NCBI Gene 27250] {aka H731}, VIM (vimentin) [NCBI Gene 7431], NES (nestin) [NCBI Gene 10763] {aka Nbla00170}, SLC7A5 (solute carrier family 7 member 5) [NCBI Gene 8140] {aka 4F2LC, CD98, D16S469E, E16, LAT1, MPE16}, TIA1 (TIA1 cytotoxic granule associated RNA binding protein) [NCBI Gene 7072] {aka ALS26, TIA-1, WDM}, ELAVL1 (ELAV like RNA binding protein 1) [NCBI Gene 1994] {aka ELAV1, HUR, Hua, MelG}, PTBP1 (polypyrimidine tract binding protein 1) [NCBI Gene 5725] {aka HNRNP-I, HNRNPI, HNRPI, PTB, PTB-1, PTB-T}, CD44 (CD44 molecule (IN blood group)) [NCBI Gene 960] {aka CDW44, CSPG8, ECM-III, ECMR-III, H-CAM, HCELL}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, RNASE1 (ribonuclease A family member 1, pancreatic) [NCBI Gene 6035] {aka RAC1, RIB1, RNS1}, PLAUR (plasminogen activator, urokinase receptor) [NCBI Gene 5329] {aka CD87, U-PAR, UPAR, URKR}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, GRB10 (growth factor receptor bound protein 10) [NCBI Gene 2887] {aka GRB-IR, Grb-10, IRBP, MEG1, RSS}, FOS (Fos proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 2353] {aka AP-1, C-FOS, p55}, RPS6KB1 (ribosomal protein S6 kinase B1) [NCBI Gene 6198] {aka PS6K, S6K, S6K-beta-1, S6K1, STK14A, p70 S6KA}, PTK2B (protein tyrosine kinase 2 beta) [NCBI Gene 2185] {aka CADTK, CAKB, FADK2, FAK2, PKB, PTK}, GIGYF2 (GRB10 interacting GYF protein 2) [NCBI Gene 26058] {aka GYF2, PARK11, PERQ2, PERQ3, TNRC15}
- **Diseases:** HCC (MESH:D006528), Cancer (MESH:D009369), Luminal B (MESH:D006509), AS (MESH:C536589), ovarian, and endometrial cancer (MESH:D004714), TNBC (MESH:D064726), carcinogenesis (MESH:D063646), breast cancer (MESH:D001943), metastases (MESH:D009362), oncogenes (MESH:D000074723)
- **Chemicals:** Dulbecco's modified Eagle's medium (-), methionine (MESH:D008715), MgCl2 (MESH:D015636), acetonitrile (MESH:C032159), cysteine (MESH:D003545), SDS (MESH:D012967), TFA (MESH:D014269), pyruvate (MESH:D019289), formic acid (MESH:C030544), LMB (MESH:C038753), HCl (MESH:D006851), Methanol (MESH:D000432), GlutaMAX (MESH:C054122), glucose (MESH:D005947), hydrocortisone (MESH:D006854), salt (MESH:D012492), bromophenol blue (MESH:D001978), sodium deoxycholate (MESH:D003840), CO2 (MESH:D002245), Lipofectamine 2000 (MESH:C086724), PBS (MESH:D007854), DTT (MESH:D004229), HS (MESH:D006859), FA (MESH:D005492), Hepes (MESH:D006531), cycloheximide (MESH:D003513), LPS (MESH:D008070), NaCl (MESH:D012965), Triton X-100 (MESH:D017830), NP-40 (MESH:C010615), EDTA (MESH:D004492), F12 (MESH:C007782), glycerol (MESH:D005990), PVDF (MESH:C024865), sucrose (MESH:D013395)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** S457A, Ser457
- **Cell lines:** MDA-MB-231 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0062), PC3 — Homo sapiens (Human), Prostate carcinoma, Cancer cell line (CVCL_0035), MCF10A — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_0598)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12862386/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12862386/full.md

## References

42 references — full list in the complete paper: https://tomesphere.com/paper/PMC12862386/full.md

---
Source: https://tomesphere.com/paper/PMC12862386